GovGazette
Menu

Historical award

Diasorin Molecular, LLC

This record is historical buying context, not open work.

How current is this award history?

Fiscal year 2025: data through (15 days old).

Fiscal year 2026: data through (15 days old).

Official release availability details

Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Current award value
$30,954,000.00
Potential award value
$30,954,000.00
Total obligated to date
$30,954,000.00

Recorded work

POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS PLATFORM FOR A DISTRIBUTED PHARMACY NETWORK IN THIS EFFORT, LUMINEX CORPORATION, A DIASORIN COMPANY, AIMS TO UNLOCK THIS UNREALIZED POTENTIAL FOR DISEASE DETECTION AND CONTROL BY DEVELOPING, VERIFYING AND C

Award activity

Obligations in covered fiscal years
$0.00
Transactions in covered fiscal years
2

Award value and obligated funds describe different amounts. Review the official record for the full transaction history.

Record identifierCONT_AWD_75A50122C00078_7505_-NONE-_-NONE-